Saturday, November 21, 2026

Al Shera’a, DEWA’s headquarters, wins first place in the YeS Honor Awards at the COP31 International Sustainable Buildings Competition

 In a new achievement that underscores Dubai’s pioneering position in smart and sustainable buildings, Al Shera’a, the headquarters of Dubai Electricity and Water Authority (DEWA), has won the first place in the YeS Honor Award–Sustainable Design category, in the COP31 International Sustainable Buildings Competition. The award was launched by the COP31 Presidency with the support of the Global Alliance for Buildings and Construction, hosted by the United Nations Environment Programme, during COP31 in Antalya, Türkiye.


HE Saeed Mohammed Al Tayer, MD&CEO of DEWA, received the award in the presence of HE Amna bint Abdullah Al Dahak, UAE Minister of Climate Change and Environment, from HE Hasan Suver, Deputy Minister of Environment, Urbanisation and Climate Change of the Republic of Türkiye, representing the COP31 Presidency.


The competition attracted more than 1,000 buildings from 99 countries, evaluated by an international jury of experts appointed by UNEP. The award recognises excellence in sustainable design, indoor environmental quality, resource selection and energy performance. Al Shera’a was selected for its integration of smart building technologies, sustainable design principles and clean energy solutions, enhancing resource efficiency and environmental performance.


Al Shera’a features an integrated cognitive system that seamlessly connects and coordinates all operational systems. The system incorporates more than 110,000 smart sensors that monitor environmental and operational data in real time, alongside more than 1,500 wireless access points and over 3,200 network devices. It generates more than 1.9 million automated control commands daily, enhancing operational integration and efficiency.


Al Shera’a generates more than 7,500 megawatt-hours of renewable energy annually through photovoltaic (PV) solar panels covering more than 26,000 square metres across its roof and façades, enabling it to generate more clean energy than it consumes. Its solar PV systems have a combined installed capacity of approximately five megawatts (MW), distributed across two main systems. The first comprises 251 building-integrated photovoltaic panels covering approximately 9,000 square feet of façade area, with an installed capacity of 187 kilowatts (kW). The second comprises approximately 8,400 solar panels installed on the roof, façade fins, at ground level and on solar shading structures. The rooftop panels cover more than 200,000 square feet.



Permalink

https://www.aetoswire.com/en/news/dewa18112026e


Contacts

Mosaad Abdelrahman


media@dewa.gov.ae


00971507692079

Friday, November 20, 2026

teamLab Biovortex Kyoto to Open 'Teahouse in a Sea of Light' for Savoring Tea. On View from Friday, November 20. Artworks Including Tea in Spontaneous Order on View

 KYOTO, Japan - Friday, 20. November 2026 AETOSWire  



 


(BUSINESS WIRE) -- teamLab Biovortex Kyoto opens ‘Teahouse in a Sea of Light’ on Friday, November 20, 2026, where visitors can savor tea within the Sea of Solidified Light.

Artworks exhibited in the teahouse, including Tea in Spontaneous Order, are now unveiled.


Teahouse in a Sea of Light

A space for savoring tea within a sea of light.


When a cup of tea is made, the artwork is born.

The tea interacts with nearby tea and the sea of light, creating a time structure throughout the entire space of the artwork. Visitors drink part of this formed order itself.


Coinciding with the opening of ‘Teahouse in a Sea of Light,’ Pocket Garden of Eternal Existence is newly unveiled at the museum's entrance gate.


teamLab Biovortex Kyoto

teamLab Biovortex Kyoto is teamLab's largest museum in Japan, based on the concept of Universe of Existence, Universe of Perception.

Located within walking distance of Kyoto Station and spanning over 10,000 square meters, the museum features more than 50 artworks, including artworks based on the concept of Environmental Phenomena as well as Athletics Forest, a complex, multi-dimensional creative athletic space, and Future Park, a collaborative space for co-creation, which are both part of teamLab’s educational projects.

teamLab Biovortex Kyoto marked its one-year anniversary on October 7, 2026, reaching over 1.3 million visitors from 167 countries and regions.


teamLab Biovortex Kyoto

https://www.teamlab.art/e/kyoto/

#teamLabKyoto

21-5 Higashikujo Higashi-Iwamotocho, Minami-ku, Kyoto

https://maps.app.goo.gl/hykGEnPfHjujfabP7


Hours

9:00 AM – 9:00 PM

*Last entry: 7:30 PM


Closed

Tuesday, December 15

Tuesday, January 19

*Closed days are subject to change. For the latest information, please check the official website.


Press Kit

https://www.dropbox.com/scl/fo/93lvrprtgnfgv7fetmdkh/AEWRAiT_cvPAO96U6t39MTo?rlkey=y32z92c7awdpeux6i9a5e7atk&st=z7le6598&dl=0


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20261117922442/en/



Permalink

https://www.aetoswire.com/en/news/2011202659237


Contacts

Media Inquiries

teamLab

Media Inquiries: https://forms.gle/LnSSKQtgXpSfrB917

E-mail: lab-pr-info@team-lab.com

GE HealthCare’s Phase 2 Results Support Advancement of Investigational Manganese-Based MRI Contrast Agent Mangaciclanol Into Phase 3 of LUMINA Clinical Trial

 CHALFONT ST. GILES, England - Thursday, 19. November 2026


Key milestone in GE HealthCare’s adaptive Phase 2/3 LUMINA clinical trial, with Phase 2 results meeting primary endpoint, showing mangaciclanol and market-leading gadolinium-based agent, gadobutrol, have similar overall diagnostic preference

Mangaciclanol was well tolerated in the Phase 2 stage, with no safety concerns identified following its administration

Mangaciclanol has received FDA Fast Track designation, recognizing its potential to address significant unmet patient needs; approximately 65 million gadolinium-enhanced MRI procedures are performed each year

GE HealthCare to present preliminary Phase 2 results at RSNA 2026 (Industry Expert Theater)

 


(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced Phase 2 results support advancement into Phase 3 for its international, multicenter LUMINA trial of mangaciclanol, with a dose selection of 0.1mmol/kg. Mangaciclanol is an investigational manganese-based magnetic resonance imaging (MRI) contrast agent (MBCA). If approved, MBCAs could offer an alternative to – or even replace – gadolinium-based contrast agents (GBCAs), the current standard of care. This is because of their potential to address concerns with gadolinium-based contrast agents around retention in the body, supply chain resiliency, and the environment. This milestone comes seven months after the first patient was dosed at Mayo Clinic in April 2026, and builds on Phase 1 results showing the agent was well tolerated.


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261119117575/en/


The Phase 2 stage of the adaptive Phase 2/3 trial design is a dose-finding study in adult patients with known or highly suspected lesions referred for contrast-enhanced MRI of the central nervous system. Participants received both mangaciclanol and gadobutrol, a gadolinium-based agent, with their images compared side by side by blinded independent readers. The primary endpoint, overall diagnostic preference, was met, with diagnostic preference similar between mangaciclanol and gadobutrol. Lesion visualization and quantitative imaging findings were generally similar, and mangaciclanol was well tolerated, with no safety concerns identified following its administration. Safety will continue to be evaluated in Phase 3. LUMINA is being conducted at clinical sites in the United States, Europe and Asia.


Dr Robert J. McDonald, M.D., Ph.D., neuroradiologist at Mayo Clinic, U.S., and one of the principal investigators of the LUMINA study, said, "For years, clinicians and patients have asked whether we can achieve the diagnostic confidence of gadolinium without the concerns around tissue retention and nephrogenic systemic fibrosis risk. These Phase 2 results are an important step toward answering that question. Seeing a manganese-based agent perform this well under blinded comparison with an established gadolinium agent is encouraging, and I look forward to what Phase 3 will show across a broader range of patients."


Kevin O’Neill, President & CEO of Pharmaceutical Diagnostics (PDx), GE HealthCare, said, “These positive Phase 2 results support dose selection for Phase 3, which will further evaluate the efficacy and safety of mangaciclanol-enhanced MRI for detecting and characterizing lesions of the central nervous system and body. As aging populations and the rising burden of chronic disease drive demand for imaging, we continue to invest in our contrast media portfolio and in what comes next. Manganese-based contrast agents have the potential to transform the MRI market, helping meet the evolving needs of clinicians and patients.”


Approximately one-third of global MRI procedures require a contrast agent,1 and around 65 million contrast-enhanced procedures are performed globally each year using GBCAs as the current standard of care.2 Unlike gadolinium, manganese is an endogenous element, present in our food, and naturally occurring and autoregulated in the body. Mangaciclanol's macrocyclic "cage-like" structure is designed to minimize the possibility of retention in the body. Gadolinium is a rare-earth metal largely dependent on mining and processing infrastructure in China, whereas manganese is an essential element abundantly available from multiple countries. Furthermore, as manganese is naturally found in water sources, MBCAs could reduce environmental concerns associated with excreted contrast agents.


Mangaciclanol has received Fast Track designation by the U.S. Food and Drug Administration (FDA), which expedites the review of new therapeutics and medical imaging agents that have the potential to address significant unmet patient needs. Mangaciclanol is an investigational agent and is not currently approved for use by the FDA or any other regulatory authority. Its safety and efficacy have not been established.


GE HealthCare’s PDx segment is a global leader in imaging agents used to support 140 million patient procedures per year globally,3 equivalent to four procedures every second. For more than 40 years, GE HealthCare contrast media has been routinely used across MR, X-ray, CT and ultrasound to enhance clinical images and support diagnosis.


GE HealthCare will present preliminary Phase 2 trial results with clinical images, at RSNA in McCormick Place, Chicago, on Tuesday 1 December 12:00-13:00 at the Industry Expert Theater in South Hall A.


References:


Contrast Agents of Magnetic Resonance Imaging and Future Perspective. Nanomaterials. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC10343825/

Recent Developments and Future Perspectives in Magnetic Resonance Imaging and Computed Tomography Contrast Media. Investigative Radiology. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC12871431/

GE HealthCare press release: GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand

About GE HealthCare Technologies Inc.


GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Advanced Imaging Solutions, Pharmaceutical Diagnostics and Patient Care Solutions segments to help clinicians deliver more personalized, precise patient care. We are a $20.6 billion business with approximately 54,000 colleagues working to create a world where healthcare has no limits.


GE HealthCare is proud to be among 2026 Fortune World’s Most Admired Companies™.


Follow us on LinkedIn, Facebook, Instagram, or visit our website for our latest news and perspectives.


Forward-Looking Statements


This release contains forward-looking statements. These forward-looking statements might be identified by words, and variations of words, such as “will,” “expect,” “may,” “would,” “could,” “plan,” “believe,” “anticipate,” “intend,” “estimate,” “potential,” “position,” and similar expressions. These forward-looking statements may include, but are not limited to, statements about the transaction, the completion and expected results of the transaction including the financial performance of the business, industry positioning, and GE HealthCare Technologies Inc.’s (“the Company’s”) business, products, growth opportunities, and strategy. These forward-looking statements involve risks and uncertainties, many of which are beyond the control of the Company. Factors that could cause the Company’s actual results to differ materially from those described in its forward-looking statements include, but are not limited to, the conditions to the completion of the transaction may not be satisfied; closing of the transaction may not occur or may be delayed; the Company may be unable to achieve the anticipated benefits of the transaction; operating costs and business disruptions (including, without limitation, difficulties in maintaining relationships with employees, customers, and suppliers) may be greater than expected; the Company may assume unexpected risks and liabilities; and completing the transaction may distract the Company’s management from other important matters. Other factors that may cause such a difference also include those discussed in the "Risk Factors" section of the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission and any updates or amendments it makes in future filings. There may be other factors not presently known to the Company or which it currently considers to be immaterial that could cause the Company’s actual results to differ materially from those projected in any forward-looking statements the Company makes. The Company does not undertake any obligation to update or revise its forward-looking statements except as required by applicable law or regulation.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20261119117575/en/



Permalink

https://www.aetoswire.com/en/news/54643994


Contacts

 

GE HealthCare Media Contact:

Polly Beaumont

M +44 7345 776251

polly.beaumont@gehealthcare.com

North Star Carbon Removal Project Selected by Government of Canada for Landmark Carbon Removal Procurement Program

MEADOW LAKE, Saskatchewan & BURNABY, British Columbia - Thursday, 19. November 2026


    Microsoft-backed Saskatchewan project developed by MLTC and Svante among only three BECCS projects selected

 

(BUSINESS WIRE) -- North Star, a planned large-scale carbon dioxide removal (CDR) project being developed by Meadow Lake Tribal Council (MLTC) and Svante Technologies Inc. (Svante), has been selected by the Government of Canada as a qualified supplier under the federal Request for Standing Offer (RFSO) for the Acquisition and Retirement of Credits from Carbon Dioxide Removal Projects.

North Star was one of only three bioenergy with carbon capture and storage (BECCS) projects selected through the competitive process, following a rigorous evaluation of technical, commercial, and procurement requirements. The selection establishes North Star as an eligible supplier for future annual federal purchases of high-quality carbon removal credits.

"This announcement marks an important step forward for Canada's carbon removal industry," said Claude Letourneau, President and CEO of Svante. "Creating reliable demand for carbon dioxide removal credits helps unlock investment, accelerate project development, and strengthen Canada's position in a rapidly growing global carbon market. Over time, carbon removals have the potential to become a strategic Canadian international export under the Paris Agreement Article 6.0 framework, generating economic value through investment and job creation, while helping organizations at home and abroad achieve their climate goals."

Located in Meadow Lake, Saskatchewan, North Star is being developed to convert sustainably sourced forestry residuals into clean energy while permanently capturing and storing biogenic carbon dioxide. The project is expected to generate durable carbon removal credits while creating economic opportunities for Indigenous communities and the broader region.

"This recognition reinforces the strength of the vision behind North Star," said Chief Jeremy Norman, Tribal Chief of MLTC. "Our Nations have long understood the importance of responsible stewardship of the land and its resources. Through North Star, we have an opportunity to create jobs, attract investment, and build an Indigenous-led economic opportunity that delivers lasting benefits for our communities while contributing to Canada's climate goals."

North Star has also secured a long-term carbon removal offtake agreement with Microsoft, positioning it among Canada's most advanced planned carbon removal projects. Beyond the voluntary carbon market, the Government of Canada’s procurement program is designed to create demand for high-quality carbon removals while helping the federal government advance climate objectives. As one of the county’s first initiatives of its kind, it represents an important step toward building a robust domestic market for engineered carbon removal.

About North Star

North Star is a planned bioenergy with carbon capture and storage (BECCS) project being developed in Meadow Lake, Saskatchewan, Canada. By utilizing sustainably sourced forestry residuals from the MLTC Bioenergy Centre to produce energy while permanently removing carbon dioxide from the atmosphere, North Star aims to deliver durable carbon removals, support Indigenous economic participation, and contribute to Canada's climate and economic objectives.

About MLTC

MLTC was formed in 1981 and represents nine First Nations located in Northwest Saskatchewan. MLTC invests in businesses to meaningfully participate in Saskatchewan's economy, supporting economic reconciliation in a rural and remote area of the province. 100% of the distributions flow to the nine First Nations, to foster local economic growth; enhance on-reserve education; healthcare; youth and elder programs; housing; and other community social and infrastructure needs.

About Svante

Svante is an integrated carbon management company headquartered in Vancouver, Canada. The company makes nanoengineered filters and modular rotating contactor machines that capture and remove CO2 in an environmentally responsible way from industrial emissions and the air. The company manufactures filters for direct air capture and develops carbon capture and storage projects from source to sink. Svante is on Fast Company’s 2026 World Changing Idea’s list, the Global Cleantech 100 Hall of Fame and TIME & Statista’s list of Top Greentech Companies of 2025. For more information, visit www.svanteinc.com.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20261118228180/en/

Permalink
https://www.aetoswire.com/en/news/1911202659223

Contacts

Media Contact
Svante
Colleen Nitta
Director, Marketing & Communications
cnitta@svanteinc.com



Announcement of the UHC High-Level Forum 2026 and Information on Press Registration

 (BUSINESS WIRE) -- The Government of Japan, the World Bank Group, and the World Health Organization (WHO) will co-host the UHC High-Level Forum 2026 in Tokyo on Saturday, December 12, 2026.


It will bring together global health leaders to discuss future actions to strengthen health financing systems and accelerate progress toward achieving universal health coverage (UHC).


Additionally, a press briefing by the Forum Secretariat will be held in a hybrid format on Friday, December 11, 2026, in Tokyo.


* UHC refers to a state where all people have access to appropriate health promotion, prevention, treatment, and rehabilitation services at affordable costs. For details, please refer to the website listed in [Reference].


1. Registration for press coverage


The sessions listed in Forum schedule below will be open for media coverage either in person or online. Please note, however, that all individuals, including reporters and photographers wishing to cover the Forum in person, are required to complete pre-registration by the Friday, November 27, 18:00 (JST) deadline, since a press ID for the Forum is required upon entering the venue. Anyone without pre-registration will not be allowed to enter the venue. In principle, no new application after the deadline will be accepted for security reasons. All individuals requiring a press ID must complete pre-registration using the Press Pre-Registration Form below. Registrants will be provided with further details, including instructions for collecting press IDs.


Individuals wishing to cover the event online, specifically those who wish to join the press briefing by the Secretariat on Friday, December 11, will receive a Zoom link. Those wishing to participate online must complete pre-registration using the Press Pre-Registration Form below by Friday, November 27, 18:00 (JST). The Secretariat will send the Zoom link to all registered participants. If you wish to change your participation format from in-person to online please also do so before the above registration deadlines.


Press Pre-Registration Form:

UHC High-Level Forum 2026 Press Registration Form


2. Forum Schedule


Date and Time


Session


Venue


Participation


Friday,

December 11


17:00-17:40


Press Briefing

by the Forum Secretariat


Tokyo


In-person or Zoom


Saturday,

December 12


AM


High-level Discussion


Tokyo


In-person or YouTube


(YouTube: Viewing only)


PM


Technical Session


In-person or YouTube


(YouTube: Viewing only)


Notes:


The schedule is currently being coordinated and may be subject to change.


For certain sessions, the number of participants may be further limited among those who have registered.


Only the sessions open to the media are listed here.


Representatives from the Government of Japan, the World Bank Group, and the World Health Organization will participate in the Press Briefing as the Forum Secretariat.


3. Issuance of Press ID and Guidelines for Media Coverage


As described under Section 1 above, details including the location and time of press ID issuance, as well as further information and guidelines for media coverage, will be provided separately to those wishing to conduct in-person media coverage later.


[Reference]


UHC High-Level Forum official website: https://uhc-forum.mhlw.go.jp/index.html

Note: The YouTube livestream on Saturday, December 12 will be available on the website above.


Ministry of Health, Labour and Welfare official website:

https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kokusai/who/newpage_who_uhc.html


World Bank official website:

Health Works Initiative: https://www.worldbank.org/ja/programs/health-works/overview


World Health Organization official website:

https://www.who.int/initiatives/universal-health-coverage-knowledge-hub


 


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20261119078562/en/



Permalink

https://aetoswire.com/en/news/2011202659239


Contacts

Contact Information

For Press Registration

UHC High-Level Forum Secretariat

Email: uhc2026-press@convention.co.jp

For Inquiries Regarding the UHC High-Level Forum

UHC High-Level Forum Preparation Office, Ministry of Health, Labour and Welfare

Contact: Mr. Ueda

Tel: +81-3-5253-1111 (Extension 8106)


 

Rimini Street to Host Investor Day on January 14, 2027, in New York City

 The Company will highlight its opportunities and unique solutions in enterprise software support and its ownership of the Agentic AI ERP market, present its sales strategy and financial model and host a panel discussion featuring Rimini Street global clients from a variety of industries


(BUSINESS WIRE) -- Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, managed services and Agentic AI ERP innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced details for its upcoming Investor Day, to be held on January 14, 2027, in New York City.


Investor Day Details


Date: January 14, 2027

Time: 8:30 a.m. – 12:30 p.m. Eastern Time

Location: New York City


In-Person Attendance: Institutional investors and analysts interested in attending the Investor Day in person may contact Rimini Street Investor Relations IR@riministreet.com for an event invitation and details. In-person space is limited and will be followed by a networking lunch with Rimini Street senior executives and client attendees.


Webcast Registration: Register for the live webcast or access the webcast through the Company's Investor Relations website.


Presentation Materials: Materials will be available on the Company's Investor Relations website on the day of the event.


Replay: A replay of the webcast will be available shortly following the event.


Investor Day Agenda


Join CEO, Seth Ravin and his Senior Executive Team who will cover the following:


Strategic Vision and Market Opportunity

An overview of Rimini Street’s strategy, competitive positioning and long-term growth opportunities.


Go-to-Market and Sales Strategy

How Rimini Street is evolving its sales model to drive cross-sell and upsell, leverage partners and alliances, expand wallet share and acquire new clients.


Enterprise Software Support

How Rimini Street is evolving and innovating its industry-leading support model and expanding availability across Oracle, SAP, VMware and more than 100 other enterprise software products.


Security Solutions

How Rimini Street is helping clients protect and secure their enterprise software environments in a world of fast-evolving threats and how Rimini Street plans to use "Good AI" to protect clients from "Bad AI."


Innovation Solutions

Rimini Street’s vision and strategy for the emerging Agentic AI ERP market and how the Company is helping clients adopt and leverage Agentic AI to drive greater productivity and value from their enterprise IT. Rimini Street will share its end-to-end AI services that include dozens of pre-designed AI solutions that deploy simply over current enterprise software releases and Rimini Agentworks™, Rimini Govern™ for AI and Rimini Agentic UX™ solutions.


Financial Model and Long-Term Value Creation

A review of Company revenue growth, profitability, cash flow, operating leverage and capital allocation priorities.


Global Client Panel

Clients from around the world and from diverse industries will discuss their experiences with Rimini Street and its solutions and discuss their visions and strategies with enterprise software, support, innovation and AI adoption.


Lunch and Executive Networking Q&A

An open opportunity to network with attendees and spend time over lunch with Rimini Street’s senior leadership team and client attendees.


About Rimini Street, Inc.


Rimini Street, Inc. (Nasdaq: RMNI), a Russell 2000® Company, is a proven, trusted global provider of end-to-end, mission-critical enterprise software support, managed services and innovative Agentic AI ERP solutions, and is the leading third-party support provider for Oracle, SAP and VMware software. The Company has signed thousands of IT service contracts with Fortune Global 100, Fortune 500, midmarket, public sector and government organizations who have leveraged the Rimini Smart Path™ methodology to achieve better operational outcomes, billions of US dollars in savings and fund AI and other innovation.


To learn more, please visit www.riministreet.com, and connect with Rimini Street on X, Facebook, Instagram, and LinkedIn.


Forward-Looking Statements


Certain statements included in this communication are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “anticipate,” “assume,” “believe,” “budget,” “continue,” “could,” “currently,” “estimate,” “expect,” “forecast,” “future,” “intend,” “may,” “might,” “outlook,” “plan,” “possible,” “goal,” “potential,” “predict,” “project,” “reflect,” “results,” “seem,” “seek,” “should,” “will,” “would” and other similar words, phrases or expressions. These forward-looking statements include, but are not limited to, statements regarding our expectations of future events, future opportunities, global expansion and other growth initiatives and our investments in such initiatives. These statements are based on various assumptions and on the current expectations of management and are not predictions of actual performance, nor are these statements of historical facts. These statements are subject to a number of risks and uncertainties regarding Rimini Street’s business, and actual results may differ materially. These risks and uncertainties include, but are not limited to, our ability to attract new clients or retain and/or sell additional products or services to existing clients; our ability to achieve and maintain an adequate rate of revenue growth and to maintain or increase our level of profitability; cost of revenue, including changes in costs associated with our efforts to grow and the results of any efforts to manage costs to align with current revenue expectations and the expansion of our offerings; the effects of increased intense competition in our industry and our ability to compete effectively; our ability to successfully educate the market regarding the advantages of our support and managed services for ERP software and to sell the products and services comprising our “Rimini Smart Path™” solutions portfolio; our ability to successfully develop, implement and commercialize our Agentic AI ERP initiatives; our intentions with respect to our pricing models, our ability to change our pricing models to compete successfully and expectations of client savings relative to use of other providers; the evolution of the ERP software management and support landscape facing our clients and prospects, including any widespread shift by clients or prospective clients to enterprise software vendors, products and releases for which we do not provide products or services; estimates of our total addressable market; the effects of seasonal trends on our results of operations, including the sales cycles for our products and services and the contract renewal cycles for vendor-supplied software support and managed services; the increasing complexity of our client engagements, including longer and more expensive sales cycles, increased pricing pressure and implementation and configuration challenges; the effects of the efforts of enterprise software vendors to sell upgrades or migrations to cloud-based versions of their enterprise software on our results of operations; our ability to scale our operations quickly enough to meet our clients’ changing needs or decrease our costs adequately in response to changing client demand; risks arising from incorporating artificial intelligence (“AI”) technologies into our products or services or using AI in our operations, or any deficiencies associated with AI technologies used by us or by our third-party vendors and service providers; the risk that agentic AI technologies may take actions beyond those intended or authorized and that our controls may not prevent, detect or remediate such actions on a timely basis; our ability to maintain, protect, and enhance our brand; the loss or disability of one or more members of our management team or other key employees and our ability to attract and retain additional qualified technical, sales and marketing personnel; our ability to expand our marketing and sales capabilities; our ability to avoid interruptions to, or degraded performance of, our services and the impact of any such interruptions or performance problems on our operations; defects or other problems in our products and services and any resulting service performance or warranty claims; interruptions or performance problems with technologies and services from third parties that we use to operate critical functions of our business; our ability to defend against cybersecurity threats and to comply with data protection and privacy regulations; our expectations regarding new product offerings, innovation solutions, partnerships and alliance programs and our ability to develop and maintain strategic partnerships; our ability to expand internationally and the risks associated with global operations, including currency exchange rate fluctuations and tax, trade and data regulations; continuing consolidation in our target sales markets, including the termination or non-renewal of client agreements as a result of consolidation activities; our wind down of support services for Oracle’s PeopleSoft software products within the required time period and the impact on future period revenue and costs incurred related to these efforts; the continuing impact of and our ability to comply with the terms of our July 2025 settlement agreement with Oracle; the impact of macro-economic trends, including inflation and changes in foreign exchange rates, as well as general financial, economic, regulatory and political conditions affecting the industry in which we operate and the industries in which our clients operate; our ability to generate significant capital through our operations or to raise additional capital necessary to fund and expand our operations and invest in new services and products; our business plan and our ability to effectively secure and manage our growth and associated investments; risks relating to retention rates, including our ability to accurately predict retention rates; our ability to protect our intellectual property; our ability to maintain an effective system of internal control over financial reporting; changes in laws or regulations, including tax laws or unfavorable outcomes of tax positions we take; tariff costs; our ability to realize benefits from our net operating losses; any negative impact of environmental, social and governance (“ESG”) matters on our reputation or business and the exposure of our business to additional costs or risks from our reporting on such matters; our credit facility’s ongoing debt service obligations and financial and operational covenants on our business and related interest rate risk; the sufficiency of our cash and cash equivalents to meet our liquidity requirements; the volatility of our stock price; the amount and timing of repurchases, if any, under our stock repurchase program and our ability to enhance stockholder value through such program; our ability to maintain our good standing with the United States and international governments and capture new contracts with public sector entities; the occurrence of catastrophic events that may disrupt our business or that of our current and prospective clients; future acquisitions of, or investments in, complementary companies, products, subscriptions or technologies; and those discussed under the heading “Risk Factors” in Rimini Street’s Quarterly Report on Form 10-Q filed on October 29, 2026, and as updated from time to time by Rimini Street’s future Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other filings by Rimini Street with the U.S. Securities and Exchange Commission. In addition, forward-looking statements provide Rimini Street’s expectations, plans or forecasts of future events and views as of the date of this communication. Rimini Street anticipates that subsequent events and developments will cause Rimini Street’s assessments to change. However, while Rimini Street may elect to update these forward-looking statements at some point in the future, Rimini Street specifically disclaims any obligation to do so, except as required by law. These forward-looking statements should not be relied upon as representing Rimini Street’s assessments as of any date subsequent to the date of this communication.


© 2026 Rimini Street, Inc. All rights reserved. “Rimini Street” is a registered trademark of Rimini Street, Inc. in the United States and other countries, and Rimini Street, the Rimini Street logo, and combinations thereof, and other marks marked by TM are trademarks of Rimini Street, Inc. All other trademarks remain the property of their respective owners, and unless otherwise specified, Rimini Street claims no affiliation, endorsement, or association with any such trademark holder or other companies referenced herein.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20261119878624/en/



Permalink

https://www.aetoswire.com/en/news/1911202659221


Contacts

Investor Relations Contact

Dean Pohl

Rimini Street, Inc.

+1 925 523-7636

dpohl@riministreet.com


Media Relations Contact

Janet Ravin

Rimini Street, Inc.

+1 702 285-3532

PR@riministreet.com


 

AMN dévoile un nouveau nœud radio multibande et multitechnologie pour accélérer le déploiement de réseaux de télécommunications à faible coût

 

MILTON KEYNES, Royaume-Uni, - mercredi, 18. novembre 2026

(GLOBE NEWSWIRE) -- Africa Mobile Networks (AMN), l’un des principaux fabricants d’équipements d’origine (OEM) spécialisés dans les petites cellules de télécommunication et les infrastructures rurales, a annoncé aujourd’hui le lancement commercial de son nœud radio multibande et multitechnologie de nouvelle génération, AMN Radio Node (ARN). Constituant le cœur technologique propriétaire du modèle de déploiement unique d’AMN, cette plateforme associe une capacité élevée, avec un débit 4G supérieur à 80 Mbps et huit canaux émetteurs-récepteurs (TRX) 2G, à une architecture compacte et à très faible consommation énergétique. Cette conception nécessite des pylônes plus légers, moins de panneaux solaires et aucune dépendance aux réseaux électriques nationaux, permettant ainsi de réduire les dépenses d’investissement (CapEx), les dépenses d’exploitation (OpEx) et le coût total de possession, tout en accélérant considérablement les délais de déploiement. Les opérateurs de réseaux mobiles (MNO) peuvent ainsi améliorer l’expérience de leurs abonnés et satisfaire de manière rentable aux obligations réglementaires de couverture dans les zones à faible densité de population.

Reposant sur une architecture avancée de radio logicielle (Software-Defined Radio), la plateforme fonctionne simultanément sur plusieurs bandes de fréquences et prend en charge les technologies 2G, 3G et 4G au sein de chacune d’elles. Grâce à une simple configuration des amplificateurs internes, le matériel peut s’adapter à n’importe quelle bande de fréquences utilisée par un opérateur, offrant ainsi une flexibilité maximale pour les déploiements à l’échelle mondiale. Les opérateurs peuvent réaffecter dynamiquement le spectre des communications vocales vers les services de données à haut débit, par mise à jour à distance, sans qu’il soit nécessaire de remonter sur les pylônes, de remplacer des équipements ou de procéder à des interventions de maintenance perturbatrices sur le terrain. En maintenant des débits de données 4G supérieurs à 80 Mbps, ce nœud permet à AMN d’étendre sa couverture à des zones rurales extrêmement isolées, plus loin que tout autre opérateur, tout en préservant sa rentabilité. Il est également optimisé pour densifier les réseaux dans les zones semi-urbaines et urbaines.

Un extrait multimédia accompagnant ce communiqué est disponible en cliquant sur ce lien.

Le système prend en charge nativement les liaisons de raccordement par satellite (satellite backhaul), au moyen de terminaux VSAT géostationnaires à haut débit et de constellations de satellites en orbite terrestre basse (LEO), en s’appuyant sur des processus automatisés de déploiement, de configuration et de gestion. Ces capacités permettent à AMN d’atteindre un rythme de déploiement rapide, compris entre 60 et plus de 100 sites par mois dans un même pays. Les opérations du réseau sont coordonnées grâce à une gestion centralisée de plus de 5 000 sites actifs, garantissant une efficacité opérationnelle et une disponibilité des services optimales.

Michael Darcy, directeur général d’AMN, a déclaré : « Réduire la fracture numérique exige de repenser les fondements économiques des infrastructures mobiles. La plateforme ARN constitue la pierre angulaire technologique de notre modèle économique. En associant un débit 4G supérieur à 80 Mbps et une solide capacité de communication vocale à une consommation énergétique extrêmement faible, elle rend l’expansion des réseaux économiquement viable là où les modèles traditionnels atteignent leurs limites. Elle nous permet de déployer les sites plus rapidement, de fonctionner en toute indépendance énergétique et de fournir aux opérateurs un réseau flexible et pérenne, leur permettant de répondre de manière rentable à leurs obligations de couverture. »

Ce lancement s’appuie sur le réseau d’AMN, qui compte plus de 5 400 stations de base opérationnelles dans dix pays d’Afrique subsaharienne et assure actuellement la connectivité de plus de 15,6 millions de personnes. AMN déploiera cette nouvelle architecture multibande sur les sites à fort trafic d’ici la fin de l’année 2026, avant d’en faire sa plateforme de référence à l’échelle mondiale en 2027.

À propos d’AMN

AMN fournit des infrastructures mobiles clés en main aux principaux opérateurs de réseaux mobiles de premier rang en Afrique. Grâce à son modèle Network-as-a-Service (NaaS), qui ne nécessite aucune dépense d’investissement (CapEx) de la part des opérateurs et ne leur fait supporter aucun risque lié aux dépenses d’exploitation (OpEx), AMN construit, possède, exploite et entretient des réseaux à haute capacité permettant d’étendre la couverture mobile dans les zones rurales à grande échelle.

Contact presse
Jennifer Darcy
jld@amn.com